Abstract:PURPOSE:To investigate whether rosiglitazone has a protective effect on retinal neural cells in diabetic rats, and to determine a possible anti-apoptotic mechanism.METHODS:Streptozotocin-induced diabetic rats and control animals were randomized evenly to receive rosiglitazone or not, effects were examined after 24 weeks. Retinal histology was examined and quantified using light microscopy; Apoptosis of retinal neural cells was determined by terminal dUTP nick-end labeling assay; Retinal ultrastructure was examined by transmission electron microscopy; Proteins levels of cleaved caspase-3, signal transduction and activators of transcription-3 (STAT3), phospho-STAT3 (p-STAT3), and suppressors of cytokine signaling 3 (SOCS3) in the retinal tissues were also determined by western blotting.RESULTS:Compared with the control group, the thickness of the overall retina, inner plexiform layer, inner nuclear layer reduced by 13.8%, 27.4% and 4.2%, respectively (p < 0.05) in the diabetic group after 24 weeks; The number of cells in the ganglion cell layer was also decreased by 18.6% (p < 0.05). There was apoptosis of retinal neurons in the diabetic rats. Diabetes also induced mitochondrial metamorphosis in ganglion cells and evident pyknosis in the outer nuclear layer. These effects were associated with increased levels of cleaved caspase-3, p-STAT3, and decreased levels of SOCS3. After treatment of rosiglitazone, the thickness of the retina and the number of cells in the ganglion cell layer were significantly greater than those in the diabetic group (p < 0.05). Rosiglitazone also attenuated the diabetic-induced apoptosis of retinal neurons and mitochondrial metamorphosis in ganglion cells. Consistent with these effects, rosiglitazone treatment also decreased cleaved caspase-3 and p-STAT3 expression and, at the same time, increased SOCS3 expression.CONCLUSIONS:Rosiglitazone attenuated diabetes-induced apoptosis in retinal neurons through activities that may involve inhibition of p-STAT3 by induction of SOCS3, which suggested that rosiglitazone might be used to prevent retinal neuronal damage in diabetes mellitus.

Glitazones Protects Beta Cell Function from Cytotoxic Cytokines Through PPAR Gammadependent Mechanisms

[Inhibitory Effects of Thiazolidinedione Upon Cytokine-Induced Apoptosis in Pancreatic Beta-Cell Line].

Thiazolidinediones Protect Mouse Pancreatic Β-Cells Directly from Cytokine-Induced Cytotoxicity Through PPARγ-dependent Mechanisms

Rosiglitazone Via Upregulation of Akt/Enos Pathways Attenuates Dysfunction of Endothelial Progenitor Cells, Induced by Advanced Glycation End Products

Rosiglitazone attenuates endothelial progenitor cell apoptosis induced by TNF-α via ERK/MAPK and NF-κB signal pathways.

Protective effect of pioglitazone on islet cell apoptosis induced by proinflammatory cytokines

Protective Effects of Rosiglitazone on Non-Alcoholic Steatohepatitis in Rats

Protective Effects of Rosiglitazone on Retinal Neuronal Damage in Diabetic Rats

Concurrently Using Rosiglitazone Prevents Glucosamine-Induced Islet Beta-Cell Apoptosis and Dysfunction.

Glucagon-Like Peptide-1 Analog-Mediated Protection Against Cholesterol-Induced Apoptosis Via Mammalian Target Of Rapamycin Activation In Pancreatic Beta Tc-6 Cells

Protective effects of pioglitazone on vascular endothelial cell dysfunction induced by high glucose via inhibition of IKKα/β-NFκB signaling mediated by PPARγ in vitro.

Pioglitazone Improves Mitochondrial Function in the Remnant Kidney and Protects Against Renal Fibrosis in 5/6 Nephrectomized Rats.

Pioglitazone Protects PC12 Cells Against Oxidative Stress Injury: an in Vitro Study of Its Antiapoptotic Effects Via the PPARγ Pathway.

Pioglitazone Protect PC12 Cells Against Oxidative Stress Injury: Involvement of Anti-apoptotic Effect and PPARγ Activation

Protection of rosiglitazone against HIT-T15 cell damage induced by glucosamine

Rosiglitazone attenuates hypoxia-induced renal cell apoptosis by inhibiting NF-κB signaling pathway in a PPARγ-dependent manner

Rosiglitazone Protects Dopaminergic Neurons Against Lipopolysaccharide-Induced Neurotoxicity Through Inhibition of Microglia Activation

Role and Mechanism of Rosiglitazone on the Impairment of Insulin Secretion Induced by Free Fatty Acids on Isolated Rat Islets

Protective Effect of Pioglitazone on Retinal Ischemia/Reperfusion Injury in Rats

Rosiglitazone Inhibits High Glucose-Induced Apoptosis in Human Umbilical Vein Endothelial Cells Through the PI3K/Akt/eNOS Pathway

Inhibitory Effects of Rosiglitazone on the Expression of Transforming Growth Factor-β_1 in Rat Mesangial Cells Cultured in High Glucose